|
|
Volumn 40, Issue 5, 2010, Pages 327-331
|
|
The clinical trials network of the society of nuclear medicine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3' FLUOROTHYMIDINE F 18;
ANTINEOPLASTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
CLINICAL ASSESSMENT;
CLINICAL RESEARCH;
DRUG INDUSTRY;
EQUIPMENT;
FUNDING;
HEALTH PROGRAM;
HEALTH SERVICE;
IMAGING;
MEDICAL SOCIETY;
METHODOLOGY;
MOLECULAR IMAGING;
NUCLEAR MEDICINE;
NUCLEAR MEDICINE TECHNICIAN;
PHANTOM;
PHYSICIAN;
POSITRON EMISSION TOMOGRAPHY;
QUALITY CONTROL;
SHORT SURVEY;
STANDARDIZATION;
TREATMENT RESPONSE;
UNITED STATES;
VALIDATION PROCESS;
|
|
EID: 77955697101
PISSN: 00012998
EISSN: None
Source Type: Journal
DOI: 10.1053/j.semnuclmed.2010.03.006 Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|
